$STZ $GM
+43.47%
$KMX $PSMT $BKE $X -2.61%
$VALE $AB -6.54%
$CBOE $LAZ $VCTR $IDYA $KROS $AMZN $ASYS $TSM -8.8%
SECTOR NEWS
CONSUMER
🔸 $STZ: Q4 EPS $2.63 (est. $2.29); sales +1.2% to $2.16B (est. $2.13B). Beer sales in line, wine/spirits beat. Selling mainstream wine brands to The Wine Group. FY28 EPS growth seen low to mid-single digits. New $4B buyback plan.
🔸 $GM: Downgraded to Neutral from Buy at UBS; target cut to $51 from $64 due to tariff impact.
🔸 $KMX: Q4 EPS $0.58 (est. $0.65); retail used sales +6.2%, comps +5.1%, wholesale units +3.1%. Revenue $6.0B (est. $5.963B).
🔸 $PSMT: Q2 EPS $1.45 (est. $1.40); sales $1.335B (est. $1.359B); comps +6.7%.
🔸 $BKE: March comps +3.7%, net sales +4.5% to $109.1M.
ENERGY, INDUSTRIALS & MATERIALS
🔸 $X: Shares fell after Trump opposed Nippon Steel’s takeover.
🔸 $VALE: Upgraded to Buy at Bank of America.
FINANCIALS
🔸 $AB: AUM fell to $784B in March from $805B in Feb.
🔸 $CBOE: Downgraded to Neutral at Bank of America.
🔸 $LAZ: March AUM $227.4B; net outflows $3.1B, market loss $5.4B.
🔸 $VCTR: Total client assets $171.4B as of March.
HEALTHCARE
🔸 $IDYA: Started Phase 1/2 expansion trial combining IDE397 with Gilead’s Trodelvy.
🔸 $KROS: Shares rise after adopting poison pill; exploring strategic options, including sale.
TECHNOLOGY, MEDIA & TELECOM
🔸 $AMZN: 2024 revenue +11% to $638B; AWS +19% to $108B; operating income +86% to $68.6B.
🔸 $ASYS: Cuts Q2 revenue forecast to $15M–$16M (from $21M–$23M) due to customer dispute.
🔸 $TSM: Q1 sales +42% to $25.6B, in line with guidance despite earthquake impact.
From X
Disclaimer: The above content reflects only the author's opinion and does not represent any stance of CoinNX, nor does it constitute any investment advice related to CoinNX.